GEMIN X PHARMACEUTICALS INC

Profile

Company Names

GEMIN X PHARMACEUTICALS INC

Addresses

400 CHESTERFIELD PARKWAY, SUITE 100, MALVERN, PA 19355

3576 AVENUE DU PARC, SUITE 4310, MONTREAL, A8 H2X 2H7

Phone Numbers

514-281-8989

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$13,175,307.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2010-05-07 
$3,916,229.00 
$8,500,000.00 
$4,583,771.00 
Equity 
1
2009-05-29 
$9,259,078.00 
$20,000,000.00 
$10,740,922.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIMOTHY 
J. 
BARBERICH 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  RESOLVYX PHARMACEUTICALS, INC.   |  EUTHYMICS BIOSCIENCE INC   |  GI DYNAMICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  TOKAI PHARMACEUTICALS INC   |  FREQUENCY THERAPEUTICS, INC.
AARON 
 
DAVIDSON 
DIRECTOR
HYPERBRANCH MEDICAL TECHNOLOGY INC   |  GEMIN X PHARMACEUTICALS INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  NEURAXON(USA), INC.   |  TRANZYME INC   |  INTACT VASCULAR, INC.   |  CARDEAS PHARMA CORP   |  FORSIGHT VISION5, INC.   |  CONAVI MEDICAL CORP.   |  PERIMETER MEDICAL IMAGING AI, INC.
D. 
MICHAEL 
DIXON 
EXECUTIVE OFFICER
GEMIN X PHARMACEUTICALS INC   |  DALCOR PHARMACEUTICALS US, LLC   |  DALCOR PHARMACEUTICALS CANADA INC.
PETER 
R. 
DOLAN 
EXECUTIVE OFFICER, DIRECTOR
GEMIN X PHARMACEUTICALS INC
ROBERT 
 
GORMAN 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  INTERPACE BIOSCIENCES, INC.   |  SERENDIPITY FROZEN LLC
ANDREW 
R. 
JORDAN 
DIRECTOR
GEMIN X PHARMACEUTICALS INC
ROBERT 
G. 
MCNEIL 
DIRECTOR
REGEN BIOLOGICS INC   |  GEMIN X PHARMACEUTICALS INC   |  INFRAREDX INC   |  ASTERES INC   |  CALCIMEDICA INC
SCOTT 
 
MORENSTEIN 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P.   |  CELATOR PHARMACEUTICALS INC   |  VELICEPT THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.   |  ANTIOS THERAPEUTICS INC.   |  PRIMMUNE THERAPEUTICS, INC.   |  PALVELLA THERAPEUTICS, INC.
ERIC 
W. 
ROBERTS 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  INVUITY, INC.   |  VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P.   |  CALCIMEDICA SUBSIDIARY, INC.   |  CALCIMEDICA, INC.
GORDON 
C. 
SHORE 
EXECUTIVE OFFICER, DIRECTOR
GEMIN X PHARMACEUTICALS INC
JEAN 
 
VIALLET 
EXECUTIVE OFFICER
GEMIN X PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-05-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-07 
2009-06-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-05-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#